🔓 Unlock the full profile of Satyanarayana Chava (Founder And Ceo At Laurus Labs), including verified contact details, financial insights, and professional associations.
See Satyanarayana Chava Full Profile
From IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: sat*****@fou******.com
Mobile: 96673*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Satyanarayana Chava founded Laurus Labs in 2005 and has been instrumental in its transformation into a leading integrated pharmaceutical company.
- Under his leadership, Laurus Labs has achieved significant growth and innovation in the pharmaceutical industry, focusing on providing high-quality solutions.
- Chava holds both a master's degree and a Ph.D. in chemistry, showcasing his strong academic background that supports his expertise in the pharmaceutical field.
- In March 2024, he received the Best CEO Award in Pharma & Health Care from Business Today, reflecting his leadership excellence in the industry.
- He has overseen numerous strategic initiatives that enhanced Laurus Labs’ capabilities in manufacturing and research and development of pharmaceutical products.
- Chava has contributed to expanding the company's global presence, successfully navigating competitive challenges in the pharmaceutical sector.
- His vision for Laurus Labs includes continuous improvement, sustainability in operations, and a commitment to enhancing patient outcomes worldwide.
| CIN/LLP | Company Name | Designation | Appointment Date |
|---|---|---|---|
| L24239AP2005PLC047518 | Laurus Labs Limited | Whole-time director | 21 Jan 2006 |
| U02423KA2005PTC036770 | Laurus Bio Private Limited | Director | 20 Jan 2021 |
| U21000TS2024FTC184449 | Krka Pharma Private Limited | Director | 12 Apr 2024 |
| U24239TG2004NPL043058 | Pharmaceuticals Export Promotion Council Of India | Director | 25 Apr 2018 |
| U72200TG2005PTC046163 | Nowpos M-Solutions Private Limited | Director | 31 Dec 2005 |
| U72300TG2014PTC092281 | Chemiasoft Private Limited | Director | 10 Jan 2014 |
| U74999MH2018PTC315497 | Immunoadoptive Cell Therapy Private Limited | Nominee Director | 09 Dec 2021 |
| CIN/LLP | Company Name | Designation | Appointment Date | End Date |
|---|---|---|---|
| U33112KA2011PLC059915 | S3v Vascular Technologies Limited | Director | 30 Sep 2013 | 07 August 2015 |
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Laurus Labs Ltd. | Executive Director & CEO | 13.5 Cr | -27.7 % |
| 2023 | Laurus Labs Ltd. | Executive Director & CEO | 18.6 Cr | -32.3 % |
| 2022 | Laurus Labs Ltd. | Executive Director & CEO | 27.5 Cr | 54.1 % |
| 2021 | Laurus Labs Ltd. | Executive Director & CEO | 17.9 Cr | 123.8 % |
| 2020 | Laurus Labs Ltd. | Executive Director & CEO | 8.0 Cr | -35.8 % |
| 2019 | Laurus Labs Ltd. | Executive Director | 12.4 Cr | -0.2 % |
| 2018 | Laurus Labs Ltd. | Executive Director & CEO | 12.5 Cr | 28.9 % |
| 2017 | Laurus Labs Ltd. | Whole Time Director & CEO | 9.7 Cr | - |
| 2016 | Laurus Labs Ltd. | Whole Time Director & CEO | - | - |